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Abstract
The motor deficiency control commonly characterizes Parkinson’s disease (PD),
resulting in impairment of neuromuscular command, because of basal ganglia
nuclei degeneration and late formation of Lewy’s bodies in the remaining dopami-
nergic (DA) neurons. Motor signals are triggered in high cortical motor areas and go
toward the midbrain regions, where the final tuning movement takes place. PD is
characterized primarily by the death of dopaminergic neurons in the regions known
as substantia nigra compacta (STNc). Mutations in a couple of genes, such as Parkin1
and DJ1, correspond to the usual familial form of the disease, due to its association
with oxidative stress and depolarization of mitochondrial membrane. However, this
form does not explain the selective pattern of apoptosis between the neuronal
dopaminergic areas of midbrain regions. In this chapter, we are putting forward the
hypothesis of oxidative stress and mitochondrial changes as the apparent most
relevant cause in PD, as well as the neuroprotective role played by Kir6.2, a
potassium-ATP channel and calcium voltage-gated v1.3.
Keywords: Parkinson’s disease, potassium-ATP channel, calcium v1.3 channel,
mitochondria ETC impairments, oxidative stress
Glossary:
1. PD nonhuman animal model: simulation of PD may be acquired using rotenone
and MPTP, two pesticides whose use leads to impairments in mitochondrial
complex-I and in consequence an outburst of oxidative species and free radicals.
2. Kir6.2/SUR1: during oxidative stress, potassium-ATP channel may act as a
neuroprotector factor, by inducing GABA release in subcortical areas, thereby
preventing neuronal glutamatergic overexcitation.
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1. Introduction
Parkinson’s disease (PD) is related to the selective loss of neurons, which contain
dopamine (DA) in substantia nigra compacta (STNc) and late formation of Lewy’s
bodies in the remaining dopaminergic (DA) neurons [1]. PD is one of the most
conditions, falling behind only Alzheimer’s disease. Parkinson’s disease prevalence
is progressive, ranging from 1% in people >60 years old until 2–4% in people >70
years old.
PD is commonly knownby thedisease of themotor deficiency process [2]. Due to its
associationwith impairments in basal ganglia, the presence of resting tremor,muscular
rigidity, bradykinesia, sleepdisturbances, gait impairment, anddifficultieswith balance
[3–5] became themost prominent footprint in PD characterization (see Figure 1) [4].
In humans, movements are coordinated by a series of high-precision steps that
begin in the regions of the prefrontal cortex and go toward the areas directly related to
movement coordination, such as supplementary area and primarymotor area [6].
From the start point, the signal follows pathways from inside the brain into the sub-
cortical regions and reaches the spinal cord and finally the skeletal muscle [7]. How-
ever, it is not enough to simply generate themotor signal and deliver it to themuscle; it
is necessary to coordinate and control the accuracy of the process generated in high
cortical regions. That is the point where basal ganglia take place on this process as a
stakeholder (Figure 1) [8].
Basal ganglia are composed of a series of subcortical nuclei scattered for the
midbrain regions, whose role extends from the motor fine-tuning, initialization, and
finalization of the movement (processes supported by the substantia nigra pars
compacta (STNc)), as well as the development of cognitive functions such as learning,
reward, and emotions, mostly supported by the ventral tegmental area (VTA) and
Figure 1.
The basal ganglia and a series of subcortical nuclei responsible for the motor fine-tuning in health brain (right)
and in PD (left). Direct pathway provides the disinhibition of the thalamus (D1 signaling in blue). Indirect
pathway, in red, will stop the movement, previously initiated. D1, dopamine receptor 1; D2, dopamine receptor
2; GPi, globus pallidus internus; GPe, globus pallidus external.
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nucleus accumbens (NC). Together, they are functionally known as the ventral and
dorsal striatum, respectively [9].
As one can see in Figure 1, in parkinsonism, the striatum plays an important role
in the pathophysiology of the disease, and the substantia nigra compacta (STNc)
emerges as the main nucleus responsible for the core mechanism related to the
initialization of the movement, assigned to the direct pathway [10]. Direct pathway
provides the disinhibition of the thalamus by the dopamine D1 signaling, performed
by STNc [11]. In opposite side, the indirect pathway will stop the movement,
previously initiated by the release of GABA from the external globus pallidus (GPe)
and substantia nigra pars reticulata (STNr) [12].
James Parkinson did the first description of the disease in 1817 in his book: An
Essay on the Shaking Palsy [13]. PD is characterized primarily by the death of
Figure 2.
Dopaminergic neurons undergo several mechanisms that may explain in part the selective cell death in
substantia nigra. Mutations associated with major PD related genes such as α-synuclein, DJ-1 and Parkin are
well characterized. It is possible that the mutated genes induced a protein imbalance that lead to the aggregation
of proteins to form the so-called Lewy’s bodies. Another key mechanism studied is the ROS imbalance in
mitochondria resulting in a diminished ATP that affect the ability of dopaminergic neuron to reach its main
functions. A plausible mechanism to be explored is the role of K-ATP channel that is sensitive to ATP/ADP
changes to govern the depolarization in GABAergic neuron.
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dopaminergic neurons in the STNc resulting in defective control of the movements
in the basal ganglia (Figure 1) [14]. However, in addition to dopamine metabolism
impairment, another pathological process implicated in the etiology of the disease is
the aggregation of alpha-synuclein (a-syn), resulting in Lewy’s body formation in
the remaining dopaminergic neurons, characterizing the non-motor symptoms of
the disease (Figure 2) [4, 5, 15].
Despite the dominant prevalence of sporadic form (90%), mutations in genes,
such as a-synuclein, DJ1, Parkin1, and others, have been implicated in the familial
pattern of PD, mainly due to their associations with oxidative stress responses and
depolarization of mitochondrial membrane. However, gene alterations in the
familial form of PD are ambiguous because they do not explain the selective pattern
of apoptosis between STNc and VTA, both formed predominantly by dopaminergic
neurons (Figure 2) [14, 16]. Another hypothesis associated to the oxidative stress
and mitochondrial changes is related to Ca+2 imbalance homeostasis in dopaminer-
gic neurons of the STNc, as well as the presence of KATP channels acting as a
metabolic sensor by coupling glucose metabolism to mitochondrial membrane
potential (Mit-ψ) (see Figures 3 and 4) [17]. In other words, understanding the
mechanism of specific vulnerability, by which only dopaminergic neurons in spe-
cific areas are associated with PD, remains an impressive challenge; however, some
evidences, that will be discussed here, may shed light in an intricate neurobiology of
Parkinson’s condition [14, 18].
Figure 3.
K-ATP and mitochondrial functions may be a potential relationship. K-ATP sensor is subjected to regulation
via several mechanisms as glucose metabolism, ATP/ADP ratio, mitochondrial decoupling, and gene expression.
K-ATP may lead the neuron to depolarize via potassium and calcium fluxes. It is reported that K-ATP has
other subtypes of receptors, for example, the mito-KATP. It is possible that the pathogenic production of ROS may
alter the function of K-ATP with protective functions. So, it is plausible that the modulation of K-ATP receptors
can be used to protect dopaminergic neurons.
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2. Substantia nigra compacta and ROS formation
The use of rotenone and MPTP, two pesticides, which act on the mitochondrial
complex-I, brought mitochondrial damage induced by oxidative stress to the center
of PD etiology. The uplift of reactive oxygen species (ROS), caused by a defective
complex-I, such as observed in PD patients, makes mitochondria the main source of
ROS in the intracellular environment (Figure 3) [19, 20]. Superoxide (O2
) and
peroxide of hydrogen (H2O2), the two main species of ROS derived from electron
transport chain (ETC) activity, seem to govern the internal state of the cell between
proliferative and apoptotic. According to this model, high levels of O2
 tend to
favor cell proliferation due to increased transcription of oncogenes, such as the
Rac1-Bcl2 pathway, whose overexpression increases mitochondrial respiration. On
the other hand, prevailing levels of H2O2 promote apoptosis, and finally, very high
rates of H2O2 promote cellular necrosis due to irreparable damage to cell physiology
(Figure 3) [21].
The hypothesis of oxidative stress and mitochondrial changes is apparently the
most relevant cause in the sporadic PD (Figure 3). However, they alone do not
explain selective dopaminergic neuron vulnerability. The key element for this may
lie in the differential expression of KATP channels (Kir6.2) between STNc neurons
and ventral tegmental area (VTA) [22]. In in vitro studies, the total decoupling of
the mitochondrial respiratory chain leads to the activation of KATP channels in all
dopaminergic neurons. However, partial decoupling of complex-I strongly affects
neurons from STNc, showing an opposite effect on KATP channels in dopaminergic
neurons of VTA, whose process increases the neuronal activity, reducing ROS
formation due to the closure of the KATP channels (Figure 4). It has been identified
Figure 4.
Glucose and energetic metabolism may regulate the function of K-ATP channel. The change in the ATP/ADP
ratio by glucose metabolism induces a response in K-ATP that blockade the potassium outward with the
subsequent loss of membrane potential. It may lead to depolarization with several functions, for example, the
release of GABA.
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that D2-autoreceptor (D2-AR) acts as an inhibitor of STNc-DA neurons in response
to local high DA release [23]. All the processes have been achieved by activation of
Kir6.2, an inward rectifier potassium channel coupled to G-protein [23]. Although
ventral tegmental area DA neurons (VTA-DA) do not present the same response in
such like condition [24], studies account for the presence of Cav
+21.3 channel as the
main responsible for this selectivity in STN-DA neurons, whose function would be
associated with the downregulation of STN-DA neuronal cell activity in response to
dangerous transient of local DA release [25].
2.1 The starting point of oxidative stress and KATP channel disposition
In PD, pathogenesis predominates the selective loss of dopaminergic neurons.
These neurons are in the STNc, with projections up to the striatum zone. The
neurochemistry of degeneration involves several molecular events triggered by
mitochondrial dysfunction with increased oxidative stress and excitotoxicity caused
by extracellular Ca+2 overflow. These events promote important changes in protein
conformation, e.g., alpha-synuclein, responsible for Lewy’s body formation, a
defective protein aggregation resulting in mitophagies and apoptosis [26–28].
Dopamine is a catecholamine synthesized from the L-dihydroxyphenylalanine
(L-dopa) of the amino acid tyrosine by the enzyme tyrosine hydroxylase (TH). In
the next step, L-dopa undergoes decarboxylation by the aromatic amino acid
decarboxylase (AADC) to generate dopamine and CO2. TH and AADC form a
complex with the vesicular monoaminergic carrier-2 (VMAT-2), facilitating the
uptake of dopamine in the monoaminergic synaptic vesicles [29]. The TH, the
AADC complex, and the VMAT-2 transporter facilitate the absorption of dopamine
in the monoaminergic synaptic vesicle, thus avoiding the oxidation of dopamine to
o-quinones by the dissociation of the hydroxyls of the catechol present in the
molecule when at p. 7.4 of the cytosol [30]. In the monoaminergic vesicle, the
stability of the molecule in the protonated form is conferred by an estimated pH of
approximately 5 [30].
Dopamine, which is not absorbed by VMAT-2, is transported freely by the
cytosol and may undergo oxidation by monoamine oxidase to give rise to
dihydroxyphenylacetic acid, methylation by ortho-methyltransferase, and structure
oxidation of catechol to o-quinone aminochrome [31]. 0-Quinones derived from
dopamine to form aminochrome are rapidly mopped by cysteines (or other thiols
present) generating forms that are oxidized to form melanotic pigments [32–34].
The action of flavenzyme FADH, such as DT-diaphorase induce the formation of
hydroquinone and ROS from reduction of o-quinones derived of freely dopamine in
the cytosol [35, 36]. Semiquinone is a highly reactive radical, and under aerobic
conditions, it catalyzes the reduction reaction of oxygen to the superoxide that
activates the redox cycle between the leucoaminochrome o-semiquinone radical
and the aminochrome [37, 38].
Aminochrome leads to the formation of species with proteins of complexes I and
III of the mitochondrial electron transport chain associated with reduced flavin ade-
nine dinucleotide (FADH2) [39]. It forms compounds with the isocitrate dehydroge-
nase, leading to mitochondrial dysfunction due to a decreased ATP production [40].
In addition, aminochrome forms adducts with alpha-synuclein protofibrils and with
Parkin leading to proteasome dysfunction, with actin leading to dysfunction in axonal
and cytoskeletal transport, aggregation of α-β tubulins leading to autophagy dysfunc-
tion [41, 42]. In PD models, the active metabolite of 1-metyl-4-phenyl-1,2,3,6-
tetrahydropyridine (MPTP), MPP+, and rotenone are mitochondrial toxins that
inhibit the NADH-quinone oxidoreductase complex respiratory [37, 43, 44].
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2.2 Mitochondrial KATP channels
Mitochondrial dysfunction seems to play a crucial role in PD [44–47]. Mito-
chondria is directly implicated in ROS generation and consequently in neuronal cell
death in vulnerable population. Mitochondrial KATP channels (mito-KATP) act as a
gate control linking metabolism with cell survival and neurotransmitter releasing
(Figures 2 and 4) [48]. Kir6.2 mito-KATP channels are encoded by KCNJ11 gene
family, whereas SUR1, the KATP channel sensor subunit, belongs to the class of
ABCC8, a subfamily of membranes transporters [49, 50].
KATP channels are triggered by the ATP/ADP rate, opening in response to
reduced levels of ATP and, closing, otherwise, linking KATP channels in a direct
relationship with the neuronal sugar metabolism and the action potential [51]. In
physiological conditions, in dopaminergic neurons, these channels are probably
closed. On the other hand, in PD model induced by MPTP administration in mice,
the ATP depletion and mitochondrial dysfunction are observed, thus triggering the
opening of the mito-KATP channels (Figure 4) [52].
Activation of KATP channels upon damage may play a neuroprotective role by
decreasing the cellular metabolic demand, reducing activation rate of the action
potential, thus leading to hyperpolarization of the dopaminergic neurons and loss of
its normal pacemaker activity [53].
KATP channels play an important role in signal transduction in the central
nervous system (CNS). For example, these channels are implicated in rest
potential of most neuronal cell controlling the duration of action potential, firing
frequency, and nonspecific intervals, thus regulating pacemaker time [54]. These
ionic channels stabilize the membrane potential and the mitochondrial matrix
volume during the ATP decline in order to increase the firing in dopaminergic
neurons, as well as activation of metabolic pathways to provide cell energy
(Figures 3 and 4) [25].
During mitochondrial dysfunction caused by oxidative stress or in the presence
of neurotoxins (MPTP or rotenone), high calcium concentration and the hyperpo-
larization of membrane potential may be involved in the reduction of cellular
activity in adult rats [52]. However, the vulnerability of dopaminergic neurons may
be related to the differential expression of KATP (Kir6.2) between STNc and VTA
neurons. Acute activation of rotenone-induced KATP channels in rat brain slices in
responsive dopaminergic neurons increases the expression of the KATP channel
subunits, the SUR1 and Kir6.2 [55]. However, the chronic effect of ATP depletion
and consequent opening of KATP channels (Kir6.2/SUR1) due to its metabolic sen-
sitivity in the vulnerable STNc and VTA-DA neurons decrease the expression of the
decoupling protein (UCP2) due to the lower degree of mitochondrial decoupling
conducted by the metabolic stress in PD [25].
The opening of the KATP channels may result in the hyperpolarization of the
neurotransmitters modulating the release of glutamate and g-aminobutyric acid
(GABA) in the substantia nigra reticulata (StNr) and in the striatum, reducing
glutamatergic transmission into the brain (Figure 4) [56]. This fact suggests the
significance of oxidative stress and mitochondrial alterations as a common remark-
able cause in the development of PD (Figures 3 and 4).
During PD development, Cav1.2 in favor of Cav1.3 is differentially expressed in
brain areas, thus resulting in an increase of neuronal susceptibility to events associ-
ated with oxidative stress [1, 24]. The hypothesis of differential expression of Cav1
subtypes to explain neuronal selective cell death remains inconclusive, but the fact
that there is a change in its prior expression throughout the brain in early stages of
the disease’s development reinforces our previous proposition that calcium imbal-
ance is a fundamental requirement to understand PD pathogenesis.
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3. Conclusions
In this review, we suggest that both mitochondrial KATP channel and
calcium1.3-voltage-gated contribute to maintain a balance between cell prolifera-
tion and apoptosis, acting as a metabolic sensor by coupling ROS and glucose
metabolism to mitochondrial membrane potential in dopaminergic neurons.
Finally, in conclusion, it may lead to a new pathway of drug development and
treatment of PD.
List of abbreviations
AADC aromatic amino acid decarboxylase
ABCC8 ATP-binding cassette subfamily C member 8
ADP adenosine diphosphate
a-syn alpha-synuclein
ATP adenosine triphosphate
Cav1.2 voltage-dependent calcium channel subunit alpha 1C
Cav1.3 voltage-dependent calcium channel subunit alpha 1D
CNS central nervous system
D2-AR dopaminergic D2-autoreceptor
DA dopaminergic
DJ1 protein deglycase 1
PD Parkinson’s disease
ETC electron transport chain
FADH2 Flavin adenine dinucleotide
GABA g-aminobutyric acid
GPe external globus pallidus
KATP potassium channels
KCNJ11 potassium voltage-gated channel subfamily J member 11
Kir6.2 subunit ATP-sensitive K+ channel
L-dopa L-3,4-dihydroxyphenylalanine
Mito-KATP mitochondrial ATP-dependent K
+ channel
mit-psi mitochondrial membrane potential
MPP+ metabolite of 1-metyl-4-phenyl-1,2,3,6-tetrahydropyridine
MPTP 1-metyl-4-phenyl-1,2,3,6-tetrahydropyridine
NADH nicotinamide adenine dinucleotide
NC nucleus accumbens
ROS reactive oxygen species
STNc substantia nigra compacta
STNr substantia nigra pars reticulata
SUR1 sulfonylurea receptor
TH tyrosine hydroxylase
UCP2 decoupling protein 2
VMAT-2 vesicular monoaminergic carrier-2
VTA ventral tegmental area
VTA-DA ventral tegmental area DA neurons
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